Noticias de SNDX_US

Noticias del mercado

Últimas noticias sobre SNDX_US — 170 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNDX_US ✕ 170 resultados
30/04/2026 SNDX_US — Stock Titan
Syndax (NASDAQ: SNDX) posts 224% Q1 revenue surge and lower loss
30/04/2026 SNDX_US — MarketScreener
Earnings Flash (SNDX) Syndax Pharmaceuticals, Inc. Reports Q1 Revenue $64.9M, vs. FactSet Est of $69.8M
30/04/2026 SNDX_US — MarketScreener
Earnings Flash (SNDX) Syndax Pharmaceuticals Posts Q1 Loss $0.48, vs. FactSet Est of $0.61 Loss
30/04/2026 SNDX_US — Stock Titan
Syndax (NASDAQ: SNDX) triples revenue as Revuforj and Niktimvo ramp
30/04/2026 SNDX_US — Yahoo Finance
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates

Syndax (SNDX) arrojó sorpresas en ganancias e ingresos de +17,95% y -7,35%, respectivamente, para el trimestre finalizado en marzo de 2026. ¿Las cifras ofrecen pistas sobre lo que le espera a la acción?

30/04/2026 SNDX_US — Stock Titan
Vanguard Capital Management holds 4.46M shares in Syndax (SNDX)
30/04/2026 SNDX_US — Stock Titan
Cancer drug sales top $100M as Syndax lines up late-2026 trial data
29/04/2026 SNDX_US — MSN ES ← EN
MSN Dinero

MSN Money

28/04/2026 SNDX_US — MSN ES ← EN
MSN Dinero

MSN Money

27/04/2026 SNDX_US — MSN ES ← EN
Vista previa de las ganancias del cuarto trimestre de 2025 de Syndax Pharmaceuticals

Syndax Pharmaceuticals Q4 2025 earnings preview

27/04/2026 SNDX_US — MSN ES ← EN
Vista previa de las ganancias del cuarto trimestre de 2025 de Syndax Pharmaceuticals

Syndax Pharmaceuticals Q4 2025 earnings preview

27/04/2026 SNDX_US — Quantisnow
Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
27/04/2026 SNDX_US — MarketScreener
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
24/04/2026 SNDX_US — GlobeNewswire
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
24/04/2026 SNDX_US — GlobeNewswire ES ← EN
Syndax anunciará los resultados financieros del primer trimestre de 2026 y organizará una conferencia telefónica y un webcast el 30 de abril de 2026

Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

24/04/2026 SNDX_US — Quiver Quantitative
Syndax Pharmaceuticals to Announce Q1 2026 Financial Results and Business Update on April 30, 2026

Syndax Pharmaceuticals publicará sus resultados financieros del primer trimestre de 2026 y realizará una conferencia telefónica en abril

24/04/2026 SNDX_US — GlobeNewswire
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

NUEVA YORK, 24 de abril de 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), una empresa biofarmacéutica en etapa comercial que avanza en innovaciones...

24/04/2026 SNDX_US — Stock Titan
Syndax to post quarterly results April 30, webcast starts at 4:30 p.m. ET

La gerencia planea una actualización comercial junto con los resultados del primer trimestre de 2026. Los inversores pueden unirse al webcast del 30 de abril a las 4:30 p.m. hora del Este; la repetición dura 90 días.

24/04/2026 SNDX_US — Sahm
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
24/04/2026 SNDX_US — Quiver Quantitative
Syndax Pharmaceuticals to Announce Q1 2026 Financial Results and Business Update on April 30, 2026

Página 5 de 9

keyboard_arrow_up